STILBETIN Drug Patent Profile
✉ Email this page to a colleague
When do Stilbetin patents expire, and when can generic versions of Stilbetin launch?
Stilbetin is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in STILBETIN is diethylstilbestrol. There is one drug master file entry for this compound. Additional details are available on the diethylstilbestrol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for STILBETIN?
- What are the global sales for STILBETIN?
- What is Average Wholesale Price for STILBETIN?
Summary for STILBETIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Patent Applications: | 4,785 |
| DailyMed Link: | STILBETIN at DailyMed |
US Patents and Regulatory Information for STILBETIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | STILBETIN | diethylstilbestrol | TABLET, DELAYED RELEASE;ORAL | 004056-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | STILBETIN | diethylstilbestrol | TABLET;ORAL | 004056-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | STILBETIN | diethylstilbestrol | TABLET, DELAYED RELEASE;ORAL | 004056-014 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | STILBETIN | diethylstilbestrol | TABLET;ORAL | 004056-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | STILBETIN | diethylstilbestrol | TABLET, DELAYED RELEASE;ORAL | 004056-012 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
